Your browser doesn't support javascript.
loading
Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection.
Hall, Erin M; Yin, Dwight E; Goyal, Rakesh K; Ahmed, Atif A; Mitchell, Grace S; St Peter, Shawn D; Flatt, Terrie G; Ahmed, Ibrahim A; Li, Weijie; Hendrickson, Richard J; August, Keith J; Myers, G Doug.
Afiliação
  • Hall EM; School of Medicine, University of Missouri Kansas City, Children's Mercy Kansas City, Kansas City, Missouri, USA.
  • Yin DE; School of Medicine, University of Missouri Kansas City, Children's Mercy Kansas City, Kansas City, Missouri, USA.
  • Goyal RK; School of Medicine, University of Missouri Kansas City, Children's Mercy Kansas City, Kansas City, Missouri, USA.
  • Ahmed AA; School of Medicine, University of Missouri Kansas City, Children's Mercy Kansas City, Kansas City, Missouri, USA.
  • Mitchell GS; School of Medicine, University of Missouri Kansas City, Children's Mercy Kansas City, Kansas City, Missouri, USA.
  • St Peter SD; School of Medicine, University of Missouri Kansas City, Children's Mercy Kansas City, Kansas City, Missouri, USA.
  • Flatt TG; School of Medicine, University of Missouri Kansas City, Children's Mercy Kansas City, Kansas City, Missouri, USA.
  • Ahmed IA; School of Medicine, University of Missouri Kansas City, Children's Mercy Kansas City, Kansas City, Missouri, USA.
  • Li W; School of Medicine, University of Missouri Kansas City, Children's Mercy Kansas City, Kansas City, Missouri, USA.
  • Hendrickson RJ; School of Medicine, University of Missouri Kansas City, Children's Mercy Kansas City, Kansas City, Missouri, USA.
  • August KJ; School of Medicine, University of Missouri Kansas City, Children's Mercy Kansas City, Kansas City, Missouri, USA.
  • Myers GD; School of Medicine, University of Missouri Kansas City, Children's Mercy Kansas City, Kansas City, Missouri, USA gdmyers@cmh.edu.
J Immunother Cancer ; 9(1)2021 01.
Article em En | MEDLINE | ID: mdl-33472856

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Choque Séptico / Receptores de Antígenos de Linfócitos T / Imunoterapia Adotiva / Leucemia-Linfoma Linfoblástico de Células Precursoras / Síndrome da Liberação de Citocina Tipo de estudo: Diagnostic_studies Limite: Adult / Child, preschool / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Choque Séptico / Receptores de Antígenos de Linfócitos T / Imunoterapia Adotiva / Leucemia-Linfoma Linfoblástico de Células Precursoras / Síndrome da Liberação de Citocina Tipo de estudo: Diagnostic_studies Limite: Adult / Child, preschool / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article